GRADING THE SEVERITY OF CONGESTIVE-HEART-FAILURE IN INFANTS

被引:192
|
作者
ROSS, RD
BOLLINGER, RO
PINSKY, WW
机构
[1] Division of Cardiology, Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI 48201
关键词
CONGESTIVE HEART FAILURE; CONGENITAL HEART DISEASE;
D O I
10.1007/BF00798207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine which variables most accurately define congestive heart failure (CHF) in infants, 41 patients (median age 2.5 months) were graded by four pediatric cardiologists for the presence and severity of CHF based on the following variables: amount of formula consumed per feeding, feeding time, history of diaphoresis or tachypnea, growth parameters, respiratory and heart rates, respiratory pattern, perfusion, presence of edema, diastolic filling sounds, and hepatomegaly. There were 19 patients graded as having no CHF, nine as mild, seven moderate, and six severe CHF. The most sensitive and specific variables (p < 0.0001) for the presence of CHF were a history of < 3.5 oz/feed, respiratory rate > 50/min, an abnormal respiratory pattern, diastolic filling sounds, and hepatomegaly. Moderate to severe CHF was present when patients took < 3 oz/feed or > 40 min/feed, had an abnormal respiratory pattern with a resting respiratory rate > 60/min, and had a diastolic filling sound and moderate hepatomegaly. Severe CHF was accompanied by a heart rate > 170/min, decreased perfusion, and severe hepatomegaly. Thus, the grading of the severity of CHF in infants should include an accurate description of these historical and clinical variables.
引用
收藏
页码:72 / 75
页数:4
相关论文
共 50 条
  • [1] THE PHARMACOKINETICS OF CAPTOPRIL IN INFANTS WITH CONGESTIVE-HEART-FAILURE
    PEREIRA, CM
    TAM, YK
    COLLINSNAKAI, RL
    THERAPEUTIC DRUG MONITORING, 1991, 13 (03) : 209 - 214
  • [2] PHARMACOKINETICS OF CAPTOPRIL IN INFANTS WITH CONGESTIVE-HEART-FAILURE (CHF)
    PEREIRA, CM
    COLLINSNAKAI, R
    TAM, YK
    BRADLEY, JM
    NG, P
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (11) : S108 - S108
  • [3] PHARMACOKINETICS OF ORAL ENALAPRIL IN INFANTS WITH CONGESTIVE-HEART-FAILURE
    LLOYD, TR
    MAHONEY, LT
    KNOEDEL, D
    MARVIN, WJ
    LAUER, RM
    CIRCULATION, 1987, 76 (04) : 266 - 266
  • [4] CURRENT MANAGEMENT OF CONGESTIVE-HEART-FAILURE IN INFANTS AND CHILDREN
    KOHR, LM
    OBRIEN, P
    NURSING CLINICS OF NORTH AMERICA, 1995, 30 (02) : 261 - 290
  • [5] PHARMACOKINETICS OF ORAL ENALAPRIL IN INFANTS WITH CONGESTIVE-HEART-FAILURE
    LLOYD, TR
    MAHONEY, LT
    KNOEDEL, D
    MARVIN, WJ
    LAUER, RM
    CLINICAL RESEARCH, 1987, 35 (06): : A908 - A908
  • [6] CONGESTIVE-HEART-FAILURE
    LEWANDOWSKI, DM
    AMERICAN JOURNAL OF NURSING, 1995, 95 (05) : 36 - 37
  • [7] CONGESTIVE-HEART-FAILURE
    KATS, BA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (06): : 738 - 738
  • [8] CONGESTIVE-HEART-FAILURE
    WERKO, L
    ACTA MEDICA SCANDINAVICA, 1987, 221 (01): : 3 - 14
  • [9] CONGESTIVE-HEART-FAILURE
    RUGGIE, N
    MEDICAL CLINICS OF NORTH AMERICA, 1986, 70 (04) : 829 - 851
  • [10] CONGESTIVE-HEART-FAILURE
    SREBRO, JP
    KARLINER, JS
    CURRENT PROBLEMS IN CARDIOLOGY, 1986, 11 (06) : 305 - 365